Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2008-05-01

FDA Approved: HYDROCHLOROTHIAZIDE — Supplemental Application (Leading Pharma, LLC)

View source ↗

Summary

The FDA approved a supplemental application for hydrochlorothiazide submitted by Leading Pharma, LLC. This action updates the drug's labeling (and/or indication…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)

Snippet

SUPPL AP for HYDROCHLOROTHIAZIDE (HYDROCHLOROTHIAZIDE)